Lock Kenneth A.
SEC CIK 1801047 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | Chief Commercial Off | 63.4K | — | $84.3K | 6 | 2022-03-01 | 2023-03-06 |
Most active insiders at ARQT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watanabe Todd | See Remarks, Dir | — | $5.32M |
| 2 | Welgus Howard G. | Dir | — | $2.43M |
| 3 | Matsuda Masaru | See Remarks | — | $2.21M |
| 4 | Burnett Patrick | See Remarks | — | $2.02M |
| 5 | Leonard Keith R | Dir | — | $997.1K |
| 6 | Curran Terrie | Dir | — | $984.0K |
| 7 | Edwards Larry Todd | See Remarks | — | $968.4K |
| 8 | Krishnamohan Neha | Dir | — | $939.5K |
| 9 | LIN SUE-JEAN | Dir | — | $898.5K |
| 10 | Gilbert Halley E | Dir | — | $455.5K |
Lock Kenneth A. made no open-market trades at ARQT in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-08 | 2023-03-06 | ARQT | Arcutis Biotherapeutics, Inc. | Lock Kenneth A. | Chief Commercial Off | S - Sale | $15.26 | -831 | 63.4K | -1% | -$12.7K | |
| D | 2023-03-06 | 2023-03-02 | ARQT | Arcutis Biotherapeutics, Inc. | Lock Kenneth A. | Chief Commercial Off | A - Grant | $0.00 | +21.0K | 64.3K | +49% | $0 |
| M | 2023-03-02 | 2023-02-28+ | ARQT | Arcutis Biotherapeutics, Inc. | Lock Kenneth A. | Chief Commercial Off | S - Sale | $15.96 | -2,368 | 43.3K | -5% | -$37.8K |
| D | 2022-03-07 | 2022-03-03 | ARQT | Arcutis Biotherapeutics, Inc. | Lock Kenneth A. | Chief Commercial Off | A - Grant | $0.00 | +13.3K | 45.0K | +42% | $0 |
| DM | 2022-03-07 | 2022-03-04+ | ARQT | Arcutis Biotherapeutics, Inc. | Lock Kenneth A. | Chief Commercial Off | S - Sale | $16.85 | -1,023 | 44.0K | -2% | -$17.2K |
| 2022-03-03 | 2022-03-01 | ARQT | Arcutis Biotherapeutics, Inc. | Lock Kenneth A. | Chief Commercial Off | S - Sale | $17.75 | -935 | 31.7K | -3% | -$16.6K |
Purchase Sale Sale after option exercise All abbreviations